The year is 2035 and the world is dealing with another pandemic, only this time it’s even worse. A bird flu strain has made the leap that scientists have long feared, evolving into a virus that spreads as quickly as COVID-19 but kills at a much higher rate. Businesses and schools have shut down. Economies have crashed. The infected are overwhelming hospitals.

In a virtual press conference, officials announce that there is hope, because the same kind of vaccine that got us through COVID will work this time as well. The catch is that it will take a few more months to develop and produce. And the death toll, already in the millions for the United States alone, is rising fast.

A reporter on the zoom call asks: Why will it take so long? Well, the officials explain, we had a chance about a decade ago to prepare for this by creating a ready-to-deploy vaccine platform that would have shaved months from the process. But our predecessors who were in charge back then killed the funding. So we don’t have that head start.

EVERYTHING ABOUT THE ABOVE SCENARIO is hypothetical—except the final part about the funding. That part happened last week.

On Tuesday, Health and Human Services Secretary Robert F. Kennedy Jr. announced that the Trump administration was canceling about half a billion dollars of federal contracts with companies and institutions that have been working to develop the next generation of mRNA vaccines.

. . .